Szu‐Yuan Wu
- Ophthalmology top 0.1%
- Glaucoma and retinal disorders 26
- Retinal Diseases and Treatments 18
- Otorhinolaryngology top 1%
- Head and Neck Cancer Studies 23
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism 19
- Breast Cancer Treatment Studies 13
- Epidemiology top 2%
-
- Cardiac, Anesthesia and Surgical Outcomes 17
-
- Diabetes Treatment and Management 16
-
- Intensive Care Unit Cognitive Disorders 14
- Co-authors
- M. Cristina LeskeBarbara NemesureAnselm HennisRobert HonkanenAndrew SchachatAlexander T.H. WuLeslie HymanJiaqiang Zhang
- Journals
- Advanced Materials (1 paper)Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (5 papers)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Szu‐Yuan Wu
358 papers receiving 8.1k citations
Hit Papers
Peers
Comparison fields: 5 of 197
- Ophthalmology 2.6k
- Radiology, Nuclear Medicine and Imaging 2.0k
- Otorhinolaryngology 304
- Cancer Research 618
- Epidemiology 1.3k
Countries citing papers authored by Szu‐Yuan Wu
This map shows the geographic impact of Szu‐Yuan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Szu‐Yuan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Szu‐Yuan Wu more than expected).
Fields of papers citing papers by Szu‐Yuan Wu
This network shows the impact of papers produced by Szu‐Yuan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Szu‐Yuan Wu. The network helps show where Szu‐Yuan Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Szu‐Yuan Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 18 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 1 | |
| 11 | 2022 | 12 | |
| 12 | 2022 | 7 | |
| 13 | 2021 | 4 | |
| 14 | 2020 | 7 | |
| 15 | 2019 | 53 | |
| 16 | 2018 | 17 | |
| 17 | 2018 | 13 | |
| 18 | Diminazene aceturate: an antibacterial agent for Shiga-toxin-producing Escherichia coli O157:H7 | 2016 | 1 |
| 19 | High expression of S100A8 gene is associated with drug resistance to etoposide and poor prognosis in acute myeloid leukemia through influencing the apoptosis pathway | 2016 | 1 |
| 20 | 1976 | 1 |
About Szu‐Yuan Wu
Szu‐Yuan Wu is a scholar working on Otorhinolaryngology, Ophthalmology and Cancer Research, having authored 385 papers that have together received 8.3k indexed citations. Recurring topics across this work include Glaucoma and retinal disorders (26 papers), Head and Neck Cancer Studies (23 papers), Cancer, Lipids, and Metabolism (19 papers), Retinal Diseases and Treatments (18 papers), Cardiac, Anesthesia and Surgical Outcomes (17 papers), Diabetes Treatment and Management (16 papers), Intensive Care Unit Cognitive Disorders (14 papers) and Breast Cancer Treatment Studies (13 papers). The work is most often cited by research in Ophthalmology (2.6k citations), Radiology, Nuclear Medicine and Imaging (2.0k citations) and Otorhinolaryngology (304 citations). Szu‐Yuan Wu has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include M. Cristina Leske, Barbara Nemesure, Anselm Hennis, Anselm Hennis, Robert Honkanen, Andrew Schachat, Alexander T.H. Wu, Leslie Hyman, Jiaqiang Zhang and Kevin Sheng‐Po Yuan. Their work appears in journals such as Advanced Materials, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.